Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ovarian cancer: profiling a deadly disease at the MUHC

02.05.2008
Ovarian cancer (OC) is the fourth leading cause of death from cancer in Canadian women yet 90% of OC patients could be saved with an early diagnosis.

MUHC Gynecological Oncologist, Dr. Lucy Gilbert, has made it her mission to profile and track this killer, which takes so many lives because of delayed diagnosis. She has put together a talented team of professionals, and with the financial support of the McGill University Health Centre (MUHC) Foundation's "Best Care For Life" campaign and the Canadian Institute of Health Research (CIHR) has devised a trial to help identify this disease at a curable stage (i.e. Stage I).

"In the month of May, we celebrate Mother's Day, a day honoring all women, mothers, wives, sisters, daughters, grandmothers, friends. In recognition of the valuable role that these women play in our lives we need to raise awareness of an insidious disease that has claimed the lives of countless women. "Ovarian cancer is an "insidious killer" which sneaks up on women in the guise of many benign symptoms, such as bloating, thickened waist line, urinary frequency, etc, so it is ignored by women and their doctors, explains Dr Gilbert. "However, in some women these symptoms are due to the presence of early ovarian cancer, which over a period of time spreads and involves vital organs and becomes incurable". The DOVE study team, has spent the last two years painstakingly setting up the "Mother of all trials," DOVE (Detecting Ovarian cancer Early) to try and nail this disease at its earliest stages. Doctors, from the MUHC have teamed up with scientists from McGill University and engineers from Concordia to pool their expertise to work on the detection strategy.

In addition to the expertise of its doctors, nurses and researchers, the DOVE team benefits from the support of the MUHC Foundation, which has raised more than $300,000 in support of the Women's Health Mission of the MUHC through the sales of its bestselling cookbook Montreal Cooks. These funds are being used to purchase essential equipment as well as high-tech tools for the treatment of women with cancer, such as a Gamma Detection System probe and an Endo-Vaginal Ultrasound that Dr. Gilbert will use in her DOVE trial.

Montreal Cooks was developed by volunteer Karen Dubrofsky, who announced the reissue and national distribution of this culinary masterpiece. "I am thrilled that the first printing was a sell-out, and am proud to support Dr. Gilbert's important research," said Dubrofsky. "With Shoppers Drug Mart carrying the book across Canada, I am confident the second printing will be just as successful."

The principal goal of Dr. Gilbert's research is to produce a diagnostic probability tool, which would be made available on the internet for women with symptoms and their doctors to use as a decision aid. It would to help them decide whether their symptoms indicate a justifiable risk of OC, enough to warrant urgent diagnostic testing. This will be the first tool of its kind in the world aimed at helping patients determine if they need further testing for ovarian cancer. All existing decision aids are intended to help patients or doctors decide on treatment after diagnosis. The trial will also allow the team to develop a software program that would minimize over-diagnosis or missed diagnosis, which are all too common when non-experts perform endovaginal ultrasounds. A laboratory component of this project will focus on determining the specific molecular markers to identify early stage disease.

The success of this colossal research project hinges on the participation of all women in Montreal over the age of 50, who have the appropriate symptoms. Of the 350 ovarian cancers diagnosed each year in Montreal, 75% are diagnosed in advanced stages (III / IV) and only 20% at stage I. The DOVE team wants these figures reversed. The list of these signs is available online at the following address www.muhc.ca/studies/dove , where people will also find the exact procedure to follow in order to take part in the DOVE study. The first step will involve contacting the hotline 1-866-716-3267 where candidates will be given a questionnaire to decide on their eligibility. Those who enroll will be given the appropriate diagnostic tests, and will benefit from a 6 months follow-up.

Dr. Gilbert is the Director of the MUCH Division of Gynecological Oncology and a researcher in the Human Reproduction and Development Axis of the Research Institute of the MUHC.

For more information on Montreal Cooks and where to buy it, visit the MUHC Foundation's Web site: www.muhcfoundation.com.

The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University--the Montreal Children's, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge. www.muhc.ca

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, the university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 600 researchers, nearly 1200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec. For further details visit: www.muhc.ca/research.

The McGill University Health Centre Foundation
The McGill University Health Centre (MUHC) is currently engaged in a landmark redevelopment project that will ensure that it remains a world leader in patient care, teaching and research for generations to come. In support of this ambitious construction and renovation project, the MUHC Foundation, in partnership with the site-based foundations of the MUHC, has undertaken the $300 million Best Care for Life capital campaign, of which more than $150 million has already been secured. By funding critical transitional projects on the current sites and by supporting the construction and modernization of the Glen and Mountain campuses, the MUHC Foundation is ensuring that, now and in the future, the MUHC can continue to provide its patients with the best care for life.

For more information please contact:

Isabelle Kling
Communications Coordinator (research)
MUHC Public Relations and Communications
(514) 934-1934 #36419
isabelle.kling@muhc.mcgill.ca
Seeta Ramdas
Communications Coordinator
MUHC Public Relations and Communications
(514) 934-1934 #34320
seeta.ramdas@muhc.mcgill.ca

Isabelle Kling | MUHC
Further information:
http://www.muhcfoundation.com
http://www.muhc.ca/research

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>